Concepedia

Author

A. Harstrick

Medizinische Hochschule Hannover

Also Known As

A HARSTRICK, A Harstrick, A. HARSTRICK, A. Harstrick, Andreas Harstrick

184

Publications

10.7K

Citations

38

H-Index

66

Concepts

All Affiliations

Medizinische Hochschule HannoverWest German Heart and Vascular Center EssenWest Cancer CenterRoswell Park Comprehensive Cancer CenterUniversity of Tübingen
AH

About

A. Harstrick is an author at Medizinische Hochschule Hannover specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

52

2.4K

2

Health Sciences

6

6

273

3

Biochemistry

2

2

189

4

Biomedical Engineering

2

2

40

5

Natural Sciences

1

1

155

A. Harstrick

×

81

Publications

9.8K

Citations

35

H-Index

YearCitations

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

David Cunningham, Yves Humblet, Salvatore Siena,

New England Journal of Medicine

2004

5K

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

José Baselga, José Trigo, Jean Bourhis,

Journal of Clinical Oncology

2005

491

Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

Wilfried Eberhardt, H. Wilke, Georgios Stamatis,

Journal of Clinical Oncology

1998

330

Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor

U. Vanhoefer, Mitra Tewes, Federico Rojo,

Journal of Clinical Oncology

2003

259

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.

Christian Kollmannsberger, J. Beyer, Jean‐Pierre Droz,

Journal of Clinical Oncology

1998

204

Phase I/II Study of Cetuximab in Combination With Cisplatin or Carboplatin and Fluorouracil in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Jean Bourhis, Fernando Rivera, Ahmad Awada,

Journal of Clinical Oncology

2006

172

First-Line High-Dose Chemotherapy Compared With Standard-Dose PEB/VIP Chemotherapy in Patients With Advanced Germ Cell Tumors: A Multivariate and Matched-Pair Analysis

Carsten Bokemeyer, Christian Kollmannsberger, Christoph Meisner,

Journal of Clinical Oncology

1999

162

Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines

Dirk Strumberg, A. Harstrick, Kathia Doll,

Anti-Cancer Drugs

1996

155

Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer

Carsten Bokemeyer, J. Beyer, Bernd Metzner,

Annals of Oncology

1996

139

Gemcitabine in Patients With Relapsed or Cisplatin-Refractory Testicular Cancer

Carsten Bokemeyer, A. Gerl, P. Schöffski,

Journal of Clinical Oncology

1999

139

Page 1